Becton, Dickinson and Company (BDX)

Revenue Breakdown

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
Medication Delivery Solutions Revenue	4.71B	4.58B
Specimen Management Revenue	1.99B	1.87B
Medication Management Solutions Revenue	3.53B	3.47B
Advanced Patient Monitoring Revenue	1.22B	1.08B
BioPharma Systems Revenue	2.44B	2.32B
Integrated Diagnostic Solutions Revenue	-	3.71B
Peripheral Intervention Revenue	2.13B	2.00B
Urology and Critical Care Revenue	1.77B	1.65B
Surgery Revenue	1.67B	1.57B
Diagnostic Solutions Revenue	-	1.84B
Biosciences Revenue	-	1.46B
Revenue (Other)	-	-3.71B
Revenue (Total)	19.46B	21.84B

Revenue Breakdown 2

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
BioPharma Systems Revenue	2.44B	2.32B
Medical Essentials Revenue	6.70B	6.45B
Connected Care Revenue	4.75B	4.56B
Interventional Revenue	5.57B	5.22B
Revenue (Total)	19.46B	21.84B

Revenue by Geography

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
United States Revenue	12.06B	11.44B
International Revenue	7.40B	7.10B
Revenue (Other)	-1.00M	3.30B
Revenue (Total)	19.46B	21.84B

Revenue Breakdown 3

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
Medical Revenue	-	11.46B
Life Sciences Revenue (Pre-FY2026 Reporting)	-	5.17B
Interventional Revenue (Pre-FY2026 Reporting)	5.57B	5.22B
Revenue (Total)	19.46B	21.84B

Data Source: Fiscal.ai Last updated: Nov 5, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error